Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

Claudio Borghi,1 Ettore Ambrosioni,1 Stefano Omboni,2 Arrigo FG Cicero,1 Stefano Bacchelli,1 Daniela Degli Esposti,1 Salvatore Novo,3 Dragos Vinereanu,4 Giuseppe Ambrosio,5 Giorgio Reggiardo,6 Dario Zava7 1Unit of Internal Medicine, Policlinico S Orsola, University of Bologna, Bologna, Italy; 2Itali...

Full description

Bibliographic Details
Main Authors:	Borghi C, Ambrosioni E, Omboni S, Cicero AFG, Bacchelli S, Degli Esposti D, Novo S, Vinereanu D, Ambrosio G, Reggiardo G, Zava D
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-07-01
Series:	ClinicoEconomics and Outcomes Research
Online Access:	http://www.dovepress.com/cost-effectiveness-of-zofenopril-in-patients-with-left-ventricular-sys-a13600

Similar Items

Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies
by: Claudio Borghi, et al.
Published: (2017-07-01)

Zofenopril and ramipril in patients with left ventricular systolic dysfunction after acute myocardial infarction: A propensity analysis of the Survival of Myocardial Infarction Long-term Evaluation (SMILE) 4 study
by: Claudio Borghi, et al.
Published: (2016-09-01)

Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies
by: Borghi C, et al.
Published: (2018-07-01)

Effects of treatment with zofenopril in men and women with acute myocardial infarction: gender analysis of the SMILE Program.
by: Flavia Franconi, et al.
Published: (2014-01-01)

Effects of the concomitant administration of xanthine oxidase inhibitors with zofenopril or other ACE-inhibitors in post-myocardial infarction patients: a meta-analysis of individual data of four randomized, double-blind, prospective studies
by: Claudio Borghi, et al.
Published: (2018-06-01)

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study
by: Claudio Borghi, et al.
Published: (2008-06-01)

Zofenopril and incidence of cough: a review of published and unpublished data
by: Omboni S, et al.
Published: (2011-11-01)

COMPARISON BETWEEN ZOFENOPRIL AND RAMIPRIL IN COMBINATION WITH ACETYLSALICYLIC ACID IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTER, EUROPEAN STUDY (SMILE-4)
by: C. Borghi
Published: (2012-08-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

P3.07 OXYGEN CONSUMPTION KINETICS IN SUPRA-ANAEROBIC THRESHOLD CONSTANT LOAD EXERCISES ALLOW TO QUANTIFY IN TRAINED AND UNTRAINED SUBJECTS CYTOCHROME C-OXIDASE INHIBITION BY NITRIC OXIDE AND SHOW THIS DIRECT EFFECT AFTER NITRATE
by: D. Maione, et al.
Published: (2010-12-01)

P14.08 THE OXYGEN CONSUMPTION-ON KINETICS IN THE SUB ANAEROBIC THRESHOLD CONSTANT LOAD EXERCISES FOR ENDOTHELIUM-DEPENDENT VASODILATATION EVALUATING IN THE MUSCLE MICROCIRCULATION
by: D. Maione, et al.
Published: (2010-12-01)

The effectiveness of zofenopril in patients with cardiovascular disease
by: V G Kukes, et al.
Published: (2014-06-01)

Zofenopril versus ramipril in the early phase of acute myocardial infarction with systolic dysfunction: A retrospective study
by: Xiaoyang Liu, et al.
Published: (2020-09-01)

ACE inhibitor zofenopril effectiveness in arterial hypertension treatment
by: D. A. Napalkov, et al.
Published: (2008-12-01)

Zofenopril pri lechenii ostrogo infarkta miokarda
by: S N Tereshchenko, et al.
Published: (2008-06-01)

OPTIMISATION OF ARTERIAL HYPERTENSION PHARMACOTHERAPY IN PATIENTS WITH METABOLIC SYNDROME: POTENTIAL OF ZOFENOPRIL
by: T. E. Morozova, et al.
Published: (2011-08-01)

ZOFENOPRIL PLUS HYDROCHLOROTHIAZIDE COMBINATION THERAPY FOR THE TREATMENT OF MILD TO MODERATE HYPERTENSION
by: A. Zanchetti, et al.
Published: (2011-10-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction
by: Bart Westendorp, et al.
Published: (2004-03-01)

СHOICE OF ZOFENOPRIL AND HYDROCHLOROTHIAZIDE COMBINATION IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: N. A. Dzhaiani
Published: (2016-01-01)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.
by: Lyudmila Gennadievna Ratova, et al.
Published: (2009-09-01)

Physicochemical characterization of zofenopril inclusion complex with hydroxypropyl-β-cyclodextrin
by: Udrescu Lucreţia, et al.
Published: (2015-01-01)

Zofenopril (Zocardis) - cardioprotective ace inhibitor; clinical pharmacology and arterial hypertension treament experience
by: D. V. Preobrazhensky, et al.
Published: (2006-02-01)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease
by: C. Napoli
Published: (2011-12-01)

Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction
by: Matteo Landolfo, et al.
Published: (2020-12-01)

POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

Zofenopril in the treatment of patients with arterial hypertension and stable coronary heart disease: effects on oxidative stress and flowdependent vasodilatation
by: F. T. Ageev, et al.
Published: (2011-06-01)

Effect of Zofenopril on regeneration of sciatic nerve crush injury in a rat model
by: Kalender Ali, et al.
Published: (2009-06-01)

Antiremodelling Efficacy and Clinical Safety of Zofenopril in Patients with Grade 1and 2 Hypertension
by: Guzal J. Abdullaeva, et al.
Published: (2015-12-01)

Modern opportunities for optimising the treatment of patients with coronary heart disease and arterial hypertension: role of zofenopril
by: A. G. Evdokimova, et al.
Published: (2012-08-01)

Right ventricular systolic echocardiographic parameters in chronic systolic heart failure and prognosis
by: Khaled E. Darahim
Published: (2014-12-01)

Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects
by: M. G Bubnova
Published: (2013-03-01)

Evaluation of the influence of the therapy with fosinopril and zofenopril on the regulatory-adaptive status of patients with diastolic chronic heart failure
by: Svetlana N. Nedvetskaya, et al.
Published: (2019-12-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

Comparative evaluation of zofenopril. Are the characteristics of angiotensin I converting enzyme inhibitors important for the practice?
by: A A Kirichenko
Published: (2014-09-01)

Predicting left ventricular systolic dysfunction - Reply
by: Landray, M, et al.
Published: (2000)

Patient Outcomes by Ventricular Systolic and Diastolic Function
by: Jacqueline Levene, et al.
Published: (2024-02-01)

Tool to improve qualitative assessment of left ventricular systolic function
by: Daniel P Walsh, et al.
Published: (2020-03-01)